Known as 4MLK, this project has been in the works for more than seven years, so it was with great celebration and fan fair that the University of Maryland, Baltimore (UMB) and Wexford Science & Technology, LLC unveiled the newest development project in the University of Maryland BioPark.
The UM BioPark is expanding in West Baltimore, with new laboratory space and state-of-the-art equipment to advance medical technology and the life sciences sector in Maryland.
This month, BD officially opened its new Innovation Center on the UM BioPark campus , which will give University of Maryland, Baltimore (UMB) students access to the company’s advanced diagnostic tools and allow them to provide feedback on new concepts and technology. Known as one of the largest global medical technology companies, BD’s new facility contains several sophisticated systems, including the BD COR™ PX/GX fully automated diagnostic system for infectious disease molecular testing, and the BD MAX™ System, which includes a variety of tests and an open system for new test development.
The University of Maryland (UM) BioPark announced today that Vita Therapeutics, a cell engineering company harnessing the power of genetics to develop cellular therapies to treat muscular dystrophies and solid tumors, has established offices and laboratory space within approximately 10,000 square feet of leased space in the BioPark. Vita Therapeutics will leverage the new space to bring together its 25+-person team under one roof for the first time with the goal of progressing its co-lead programs, VTA-100 and VTA-300. The company uses induced pluripotent stem cell (iPSC) technology to engineer specific cell types designed to replace those that are defective in patients.
This is Part Two of our series on the vibrant Baltimore medtech ecosystem gaining significant momentum in Baltimore. Part One featured five exciting companies, including CoapTech, JuneBrain, ClearMask, LifeSprout, and NextStep Robotics.
BioBuzz has been reporting on myriad medtech university system spinouts and maturing companies from the Baltimore area for a number of years; we’ve featured a number of exciting and promising individual companies. However, as we’ve stepped back a bit to examine more recent Baltimore biohub developments, it’s become clear that there is an unmistakable groundswell of medtech activity that’s transforming the Baltimore life sciences sector.